News About: Pharm. Industry
VGX International discloses cGMP based expertise
VGX International Inc., a Korean affiliate of the US-based VGX Pharmaceuticals, held its VGX2007 workshop at JW Marriott Hotel in Seoul on July 12 to enhance cooperation and exchange opinions on cGMP based new drug pr...
Parties yet to narrow differences over shady dealsRepresentatives from industry and academia had a meeting to discuss ways of eliminating irregular business practices in the domestic pharmaceutical industry on July 9 but failed...
|
New one-a-day low dose of Cialis launching soon.
Lilly Korea said that a new dosage form of Cialis one-a-day (2.5mg and 5mg) was approved in European Commission. Now, the patients with erectile dysfunction could get normal sexual life freely by taking a new Cialis p...
HS Biopharm acquires Kyungnam Pharm
HS Biopharm, local human placenta manufacturer, said on July 9 that it acquired 100 percent stake of Kyungnam Pharm owned by Green Cross Corporation (GCC) and GCC holding.
An official of HS Biopharm said that for t...
US vaccine maker to establish research and production facilities
VGX Pharmaceutical Inc., a U.S pharmaceutical company, will invest $200 million in building its Asian regional headquarters in Korea, according to the Ministry of Health and Welfare on July 9.
VGX is a leading biop...
Court backs KFDA decision to ban direct dealing
The direct dealing between pharmaceutical firms and medical institutions with more than 100 beds is illegal, according to a court ruling on July 9.
The Seoul Administrative Court noted in its ruling that Under the ...
Abbott Korea to reduce Reductil price by 40%.
The price of Reductil, an anti-obesity drug supplied by Abbott Korea, will be reduced by 40% taking effect from July 9 for promotion of the product access to more fat consumers.
A staff of Abbott Korea said "Our ow...
CoQ10 market warming upThe domestic market of co-enzyme Q10 (CoQ10) is gaining momentum with a number of manufacturers who see opportunities in the field.
Daewoong Pharm launched CoQ10 VQ last mont...
|
Hanmi's Amodipine success to be resumed with Slimmer?
Hanmi has developed a modified new anti-obesity drug based on sibutramine (Reductil) expecting a similar market success perspective with Amodipine, another modified amlodipine preparation being remarkably succeeded in...
BT expo opening from July 5 to 7 in Jeju.
The 5th Interbiz Bio-partnering and Investment Forum 2007, one of the biggest technology trading arena in the local pharmaceutical and bio industries will open at Poonglim Resort of Seoguipo city, Jeju Do in attendanc...
